Conduit Pharmaceuticals Inc (NASDAQ: CDT) is -97.93% lower on its value in year-to-date trading and has touched a low of $0.08 and a high of $7.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDT stock was last observed hovering at around $0.09 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.09, the stock is -2.35% and -7.73% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.95 million and changing 4.10% at the moment leaves the stock -92.91% off its SMA200. CDT registered -98.17% loss for a year compared to 6-month loss of -96.53%. The firm has a 50-day simple moving average (SMA 50) of $0.10236 and a 200-day simple moving average (SMA200) of $1.340825.
The stock witnessed a -13.36% gain in the last 1 month and extending the period to 3 months gives it a -34.04%, and is -2.99% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.57% over the week and 13.45% over the month.
Conduit Pharmaceuticals Inc (CDT) has around 7 employees, a market worth around $11.27M and $0.00M in sales. Distance from 52-week low is 19.14% and -98.80% from its 52-week high.
.
Conduit Pharmaceuticals Inc (CDT) Top Institutional Holders
52.0 institutions hold shares in Conduit Pharmaceuticals Inc (CDT), with institutional investors hold 7.97% of the company’s shares. The shares outstanding are 96.00M, and float is at 61.46M with Short Float at 3.84%. Institutions hold 4.06% of the Float.
Conduit Pharmaceuticals Inc (CDT) Insider Activity
The most recent transaction is an insider sale by Nirland Ltd, the company’s 10% Owner. SEC filings show that Nirland Ltd sold 1,500,000 shares of the company’s common stock on Oct 03 ’24 at a price of $0.10 per share for a total of $0.16 million. Following the sale, the insider now owns 8.4 million shares.
Conduit Pharmaceuticals Inc disclosed in a document filed with the SEC on Oct 04 ’24 that Nirland Ltd (10% Owner) sold a total of 1,368,991 shares of the company’s common stock. The trade occurred on Oct 04 ’24 and was made at $0.10 per share for $0.14 million. Following the transaction, the insider now directly holds 7.03 million shares of the CDT stock.
Still, SEC filings show that on Oct 07 ’24, Nirland Ltd (10% Owner) disposed off 939,009 shares at an average price of $0.10 for $96530.0. The insider now directly holds 6,092,000 shares of Conduit Pharmaceuticals Inc (CDT).
